JCI - Applying the discovery of the Philadelphia chromosome
The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen
Bcr-Abl阻害 | Bcr-Abl Inhibition
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
